drugset / Trial / NCT00955474

Seroquel Alone Versus Seroquel With an SSRI for Depression With Psychotic Symptoms

NCT00955474

Phase 4 Terminated 32 enrolled Massachusetts General Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to compare the efficacy and tolerability of Seroquel monotherapy for the treatment of Major Depression with Psychotic features with Seroquel plus Selective Serotonin Reuptake Inhibitor.

Timeline

Start
2008-09
Primary completion
2013-01
Completion
2013-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Citalopram Small molecule 40 mg
Comparator Escitalopram Small molecule 10 mg
Subject Quetiapine Small molecule 300 mg
Comparator Sertraline Small molecule 100 mg